Politics

Marijuana banking bill approved by Congressional Committee

Following multiple days of lengthy debate and consideration of several amendments, the House Financial Services Committee voted 45 to 15 to advance the legislation to the full body. Under the approved bill, federal banking regulators would not be able to punish financial institutions just because they work with marijuana businesses that are legal under state…

READ MORE
Politics

How can scientists in the U.S. file for patents on agricultural and medicinal products with minor innovations from what is traditional knowledge?

The problem lies with the Intellectual Property Rights (IPR) systen, under the World Trade Organization (WTO). At the end of the Uruguay Round of the General Agreement on Tariffs and Trade (GATT) negotiations in 1994, IPRs were regulated world-wide under the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS). The system was designed…

READ MORE
Politics

Legalization is… [a] viable drug policy

The market for illicit drugs represents [a massive] commodity business. With an estimated annual turnover of $426-652 billion, it is approximately one-third the size of the global oil market. By calling for legalization, we are not surrendering to the problem posed by drugs. Rather, we are advocating a more effective, lasting, and humane solution. It…

READ MORE
Biography/Memoir

Guggenheim Museum will no longer accept gifts from makers of OxyContin

The group’s mission statement asks that “museums, universities, and educational institutions worldwide remove Sackler signage and publicly refuse future funding from the Sacklers.”  Purdue Pharma started producing OxyContin, generic name oxycodone, in 1995. The drug became a billion-dollar blockbuster for the company. The Sackler family is listed as the 19th-richest in the world by Forbes…

READ MORE